Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6661 AL 6675

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Edison P.

Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.

The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence

Emekli-Alturfan E, Alturfan AA.

Mol Biol Rep. 2023 Jan;50(1):815-828. doi: 10.1007/s11033-022-07925-w. Epub 2022 Nov 3.

Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder

Nakhal MM, Aburuz S, Sadek B, Akour A.

Molecules. 2022 Oct 23;27(21):7174. doi: 10.3390/molecules27217174.

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp KO, Glotfelty EJ, Li Y, Greig NH.

Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.

Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease

Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY.

Neuroscience. 2022 Dec 15;507:139-148. doi: 10.1016/j.neuroscience.2022.11.001. Epub 2022 Nov 11.

Applications of nanobodies in brain diseases

Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G.

Front Immunol. 2022 Nov 8;13:978513. doi: 10.3389/fimmu.2022.978513. eCollection 2022.

Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?

Guidetti M, Bertini A, Pirone F, Sala G, Signorelli P, Ferrarese C, Priori A, Bocci T.

Int J Mol Sci. 2022 Nov 9;23(22):13775. doi: 10.3390/ijms232213775.

Regenerative medicine improve neurodegenerative diseases

Ashraf SS, Hosseinpour Sarmadi V, Larijani G, Naderi Garahgheshlagh S, Ramezani S, Moghadamifar S, Mohebi SL, Brouki Milan P, Haramshahi SMA, Ahmadirad N, Amini N.

Cell Tissue Bank. 2023 Sep;24(3):639-650. doi: 10.1007/s10561-022-10062-0. Epub 2022 Dec 17.

Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders

Wu C, Zou P, Feng S, Zhu L, Li F, Liu TC, Duan R, Yang L.

Mol Neurobiol. 2023 Apr;60(4):1749-1765. doi: 10.1007/s12035-022-03175-w. Epub 2022 Dec 26.

Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease

Owoyele PV, Malekzadeh S.

Niger J Physiol Sci. 2022 Dec 31;37(2):157-164. doi: 10.54548/njps.v37i2.1.

Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases

Mannan A, Singh TG, Singh V, Garg N, Kaur A, Singh M.

Curr Drug Targets. 2022;23(3):286-310. doi: 10.2174/1389450122666210707120256.

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges

Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA.

Cell Mol Life Sci. 2022 Apr 2;79(4):219. doi: 10.1007/s00018-022-04225-1.

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B.

Drug Discov Today. 2022 Jul;27(7):1994-2007. doi: 10.1016/j.drudis.2022.04.003. Epub 2022 Apr 6.

Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review

Klose J, Griehl C, Roßner S, Schilling S.

Biomolecules. 2022 May 12;12(5):694. doi: 10.3390/biom12050694.

Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review

Martins B, Vieira M, Delerue-Matos C, Grosso C, Soares C.

Mar Drugs. 2022 May 28;20(6):362. doi: 10.3390/md20060362.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias